http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6a76026147aebf2a1ede92f66f4a1ee
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Pacey |
| name | Simon Pacey |
| given-name | Simon |
| organization-name | From the Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research; Section of Medicine, The Institute of Cancer Research; The Royal Marsden Hospital, Sutton; Cancer Research UK, Drug Development Office; and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom Cambridge University Hospitals NHS Foundation Trust, CB2 0QQ Cambridge, UK.; Department of Oncology, University of Cambridge, CB2 0XZ Cambridge, UK. Emma Beddowes, Javier Garcia Corbacho, and Simon Pacey, University of Cambridge, Cambridge; James Spicer, Dimitra Repana, Teresa Szyszko, and Gary Cook, King's College London; Pui Ying Chan, Jeremy P. Steele, Peter Schmid, Michael Sheaff, and Peter W. Szlosarek, St Bartholomew’s Hospital; Ramsay Khadeir, Peter Schmid, and Peter W. Szlosarek, Queen Mary University of London, London, United Kindgom; and Monica Diaz, Xiaoxing Feng, Amanda Johnston, Jim Thomson, Bor-Wen Wu, and John Bomalaski, Polaris... 11University of Cambridge, Department of Oncology, Cambridge, United Kingdom. Translational Prostate Cancer Group Cancer Research UK (CRUK) Cambridge Cancer Centre Cambridge UK; Urological Malignancies Programme CRUK Cambridge Cancer Centre Cambridge UK; Department of Oncology University of Cambridge Cambridge UK Department of Oncology, The University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom 2Royal Marsden Hospital, Sutton, United Kingdom, and Department of Oncology, Addenbrookes Hospital, Cambridge, UK 1Cancer Research UK Centre for Cancer Therapeutics and Section of Medicine, The Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom; Authors' Affiliations: 1Barbara Ann Karmanos Cancer Institute, Departments of Medicine and Pharmacology, Wayne State University; 2Biostatistics Unit, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan; 3Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland; 4Departments of Medicine and Pharmacology Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; 5National Cancer Institute Cancer Therapy Evaluation Program Branch, Bethesda, Maryland; and 6Royal Marsden Hospital, London, United Kingdom Translational Prostate Cancer Group CRUK Cambridge Cancer Centre Cambridge UK; Department of Oncology University of Cambridge Cambridge UK Signal Transduction & Molecular Pharmacology Team, Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, SM2 5NG, UK. 8Department of Oncology, University of Cambridge, Cambridge, United Kingdom. Department of Oncology, University of Cambridge, Cambridge CB2 0QQ, UK Department of Oncology, University of Cambridge, Cambridge, UK Department of Oncology NIHR Cambridge Biomedical Research Centre University of Cambridge Cambridge UK Authors' Affiliations: 1Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, Sutton, Surrey; 2Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, UK, and Drug Development Unit, The Royal Marsden Foundation NHS Trust, Sutton, Surrey; 3Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom; and 4Cancer Research UK, Lincolns Inn Fields, London, United Kingdom 1Signal Transduction and Molecular Pharmacology Team and |
Incoming Links
Total number of triples: 50.